+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Kairomones Market by Application (Animal Behavior Research, Environmental Monitoring, Pest Control), End User (Academic & Research Institutes, Agriculture, Biotechnology & Pharma), Type, Source, Formulation - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6121399
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Kairomones, chemical signals emitted by one species that inadvertently benefit another, occupy a pivotal niche within ecological communication networks. Their significance extends across applications ranging from precision pest control to insights into animal behavior, enabling researchers and industry practitioners to decode intricate interactions in both natural and managed ecosystems. The subtlety of kairomone signaling demands sophisticated detection technologies and an interdisciplinary approach that bridges chemistry, biology, and data analytics. As scientific methodologies evolve, the capabilities to isolate, quantify, and synthesize kairomones have advanced, driving new opportunities for sustainable solutions in agriculture, pharmaceutical research, and environmental monitoring.

With growing global emphasis on environmentally friendly pest management and the reduction of synthetic pesticides, kairomones have garnered attention as a novel class of biocontrol agents. This introduction outlines the foundational principles of kairomone chemistry, explores their ecological roles, and sets the stage for a comprehensive examination of market dynamics. By contextualizing kairomones within emerging research priorities and regulatory frameworks, this section prepares decision-makers to appreciate the scientific intricacies and commercial potential that underpin this rapidly evolving field.

Navigating the Evolution of Kairomone Applications and Innovations That Are Shaping the Ecological Sensing Landscape for Sustainable Solutions

The landscape of kairomone research and application is undergoing a profound transformation driven by several converging trends. Advances in analytical instrumentation, such as high-resolution mass spectrometry and sensor-based detection platforms, have enabled researchers to capture evidence of kairomone interactions at unprecedented levels of sensitivity. In parallel, breakthroughs in synthetic biology have paved the way for custom-designed volatile profiles, allowing for tailored pest control strategies that minimize non‐target effects. Furthermore, the integration of artificial intelligence and machine learning in ecological modeling has enhanced the predictive accuracy of kairomone-based monitoring systems, fostering real-time decision support for growers and conservation managers.

Innovations in formulation science have also altered the delivery mechanisms of kairomones, enabling slow-release matrices and nanoemulsion carriers that prolong field efficacy. Digital agriculture platforms now incorporate sensor networks that collect kairomone concentration data and feed into cloud-based analytics, facilitating predictive alerts for pest outbreaks. Therefore, the confluence of detection technology, synthetic design, and digital connectivity is reshaping how stakeholders approach ecological signaling, marking a shift from trial-and-error applications toward data-driven, precision-guided interventions.

Assessing the Ripple Effects of New United States Tariff Measures on the Global Kairomone Supply Chain and Pricing Structures in 2025

In 2025, newly imposed United States tariffs on imported biochemical precursors and specialty compounds have sent reverberations through the global kairomone supply chain. As many advanced kairomone formulations rely on reagents and manufacturing processes sourced from tariff-affected regions, increased input costs have triggered a reassessment of sourcing strategies. Consequently, domestic producers are accelerating capacity expansions while forging strategic partnerships with local chemical synthesis and biotechnology facilities to reduce exposure to cross-border levies.

Moreover, the tariff environment has heightened interest in natural extraction methods, as stakeholders seek to leverage animal-, microbial-, and plant-derived sources that bypass high-duty trade corridors. This shift has prompted investment in upstream cultivation and bioprocessing infrastructure, particularly in regions where regulatory landscapes incentivize bio-based solutions. In addition, the uncertainty around future trade policies has underscored the importance of flexible supply chain architectures, encouraging agile manufacturing models that can pivot between natural feedstocks and synthetic routes. Ultimately, these tariff pressures are accelerating domestic innovation, reshaping cost structures, and reinforcing the strategic value of localized production in the kairomone industry.

Decoding the Multifaceted Segmentation Framework of the Kairomone Market to Reveal Strategic Application and End User Dynamics

A nuanced understanding of the kairomone market emerges through a multifaceted segmentation framework spanning applications, end users, compound types, sources, and formulations. Within application segments, animal behavior research delves into predator-prey interactions, environmental monitoring tracks ecological shifts, and pest control subdivides into crop protection and urban pest management, each demanding unique signal profiles. Pharmaceutical exploration harnesses kairomone pathways to inform drug discovery, while plant defense research investigates chemical cues that bolster resistance against herbivores.

End user perspectives reveal that academic and research institutes, encompassing both research laboratories and universities, serve as primary innovation drivers, advancing foundational science. The agriculture sector, comprising crop protection and livestock management, translates those discoveries into field-ready solutions. Biotechnology and pharmaceutical enterprises leverage biotechnological and pharmaceutical processing to scale production, and the cosmetics industry explores kairomone analogs for aroma modulation. When considering compound classifications, non-volatile peptides and proteins contrast with volatile compounds classified as nitrogen or sulfur volatiles, affecting both detection methods and delivery tactics. Source distinctions bifurcate into natural origins-spanning animal-derived, microbial-derived, and plant-derived extractions-and synthetic origins achieved through biotechnological production or chemical synthesis. Finally, formulation modalities range from gas-phase aerosols and vapors to liquid emulsions and solutions and solid granules and powders, each optimized for specific deployment environments. By weaving these segmentation dimensions together, stakeholders can tailor research, development, and commercialization pathways that align with precise performance criteria.

Examining Regional Variations in Kairomone Adoption and Growth Drivers Across the Americas Europe Middle East Africa and Asia Pacific Markets

Regional dynamics in the kairomone domain highlight divergent adoption patterns and value drivers. In the Americas, robust investment in integrated pest management programs and extensive field trial networks have accelerated the translation of research breakthroughs into commercial applications. Public-private collaborations fostered by government incentives emphasize sustainable agriculture, driving demand for both synthetic and natural kairomone solutions. Meanwhile, North American academic consortia continue to publish high-impact research, bolstering the scientific foundation for novel formulations.

In Europe, Middle East, and Africa, stringent regulatory frameworks reinforce standards for biocontrol agents, prompting manufacturers to align product development with rigorous registration requirements. Organic agriculture certification schemes across Western Europe further incentivize the use of naturally derived kairomones, while emerging markets in the Middle East explore urban pest management solutions adapted to arid environments. African initiatives focus on cost-effective, locally sourced extraction practices, leveraging indigenous plant and microbial resources.

Across Asia-Pacific, rapid adoption is fueled by the region’s expansive agricultural output and increasing awareness of eco-friendly practices. Collaborative research hubs in Australia and New Zealand integrate sensor networks with field-scale testing, while Southeast Asian countries prioritize affordable, easy-to-apply formulations. China and India have emerged as significant players in both natural feedstock cultivation and synthetic biology platforms, balancing domestic demand with growing export ambitions.

Highlighting Leading Companies Driving Innovation Partnerships and Competitive Strategies in the Kairomone Industry

Leading companies in the kairomone ecosystem are forging innovation pathways through strategic alliances, technology platforms, and targeted acquisitions. Global agrochemical corporations are investing in biotech startups that specialize in microbial fermentation of volatile compounds, securing early access to proprietary strains. Meanwhile, specialty firms focused on pheromone and semiochemical production are expanding their footprint through joint ventures with regional distributors, aiming to strengthen supply chains and ensure rapid market penetration.

In parallel, interdisciplinary research firms are forming consortia with university laboratories to co-develop custom peptide-based kairomone analogs, enhancing specificity for niche pest targets. Partnerships between synthetic biology pioneers and formulation experts have generated advanced nanoemulsion carriers, offering controlled release profiles that extend field efficacy. Moreover, mergers between chemical synthesis specialists and bioprocessing companies are streamlining end-to-end production capabilities, from strain development to commercial batching. These collaborative models underscore a broader industry shift toward integrated value chains, where shared risk and combined expertise accelerate time-to-market for next-generation kairomone solutions.

Actionable Strategies for Industry Leaders to Capitalize on Emerging Trends and Strengthen Market Positioning in the Kairomone Sector

To harness the full potential of kairomones, industry leaders should prioritize targeted research collaborations with academic and extension networks, ensuring early access to emerging signal molecules. Investment in domestic biomanufacturing capabilities will mitigate tariff-induced cost pressures and enhance supply chain resilience. Leaders must also pursue regulatory harmonization by engaging with standards bodies to streamline product registration processes across key geographies.

Furthermore, deploying advanced digital platforms that integrate real-time sensor data with predictive analytics will empower precise application timing, reducing product waste and maximizing field efficacy. Diversification of product portfolios through the development of peptide-based non-volatile compounds alongside volatile nitrogen and sulfur derivatives will open new therapeutic and environmental monitoring markets. Finally, forging alliances with formulation and distribution specialists in high-growth regions can catalyze rapid adoption, enabling companies to capture white space opportunities in both established and emerging markets.

Comprehensive Research Methodology Design Integrating Primary and Secondary Data Approaches for Robust Kairomone Market Insights

This study employs a hybrid research methodology combining extensive secondary research with targeted primary engagements. Secondary sources include peer-reviewed journals, patent filings, regulatory databases, and industry whitepapers, providing a foundational understanding of kairomone chemistry, applications, and market activities. In parallel, primary data collection involved in-depth interviews with subject matter experts from academia, biotechnology firms, and agrochemical corporations, complemented by structured discussions with end-user representatives in agriculture and environmental management.

Quantitative validation of emerging trends leveraged proprietary surveys distributed to research laboratories and product development teams, enabling statistical analysis of adoption drivers and technology readiness levels. Data triangulation techniques reconciled insights across sources, ensuring consistency and reliability. Finally, an expert review panel comprising cross-disciplinary practitioners validated key findings and refined strategic recommendations, resulting in a robust framework for understanding the current state and future trajectory of the kairomone market.

Conclusive Reflections on Kairomone Market Dynamics and Strategic Imperatives for Sustainable Growth and Innovation Forward

The convergence of advanced detection technologies, synthetic biology innovations, and evolving regulatory landscapes positions kairomones as a cornerstone of sustainable pest management and ecological monitoring. As new tariff measures catalyze a pivot toward localized production and natural extraction methods, stakeholders are compelled to adapt supply chains and invest in domestic biomanufacturing. The segmentation framework underscores the diverse application avenues, compound classes, and formulation types that cater to distinct end-user needs.

Regional disparities highlight the importance of regulatory alignment and collaborative research ecosystems in accelerating adoption, while corporate strategies centered on partnerships and value-chain integration drive competitive differentiation. By embracing data-driven decision making, prioritizing cross-sector collaborations, and engaging proactive regulatory dialogue, organizations can unlock new growth pathways. The insights and strategic imperatives outlined herein equip decision makers to navigate the complexities of the kairomone landscape and capitalize on emerging opportunities for innovation and sustainability.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Animal Behavior Research
    • Environmental Monitoring
    • Pest Control
      • Crop Protection
      • Urban Pest Control
    • Pharmaceutical
    • Plant Defense Research
  • End User
    • Academic & Research Institutes
      • Research Laboratories
      • Universities
    • Agriculture
      • Crop Protection
      • Livestock Management
    • Biotechnology & Pharma
      • Biotechnology
      • Pharmaceutical
    • Cosmetics
  • Type
    • Non Volatile
      • Peptides
      • Proteins
    • Volatile
      • Nitrogen Volatiles
      • Sulfur Volatiles
  • Source
    • Natural
      • Animal Derived
      • Microbial Derived
      • Plant Derived
    • Synthetic
      • Biotechnology
      • Chemical Synthesis
  • Formulation
    • Gas
      • Aerosol
      • Vapor
    • Liquid
      • Emulsion
      • Solution
    • Solid
      • Granule
      • Powder
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Suterra LLC
  • ISCA Technologies, Inc.
  • Bedoukian Research, Inc.
  • Russell IPM Limited
  • Trécé, Inc.
  • Contech International, Inc.
  • Pacific Biocontrol Corporation
  • Pherobank B.V.
  • Koppert B.V.
  • Olfasense GmbH

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of synthetic kairomone analogs into precision agriculture pest monitoring systems
5.2. Commercial scaling of biotechnologically derived kairomones for sustainable crop protection strategies
5.3. Regulatory harmonization initiatives facilitating faster approval of kairomone-based biopesticides in global markets
5.4. Advancements in field delivery technologies enhancing targeted release of kairomones for pest suppression
5.5. Collaborative partnerships between agrotech firms and research institutes driving innovation in kairomone bioformulations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Kairomones Market, by Application
8.1. Introduction
8.2. Animal Behavior Research
8.3. Environmental Monitoring
8.4. Pest Control
8.4.1. Crop Protection
8.4.2. Urban Pest Control
8.5. Pharmaceutical
8.6. Plant Defense Research
9. Kairomones Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.2.1. Research Laboratories
9.2.2. Universities
9.3. Agriculture
9.3.1. Crop Protection
9.3.2. Livestock Management
9.4. Biotechnology & Pharma
9.4.1. Biotechnology
9.4.2. Pharmaceutical
9.5. Cosmetics
10. Kairomones Market, by Type
10.1. Introduction
10.2. Non Volatile
10.2.1. Peptides
10.2.2. Proteins
10.3. Volatile
10.3.1. Nitrogen Volatiles
10.3.2. Sulfur Volatiles
11. Kairomones Market, by Source
11.1. Introduction
11.2. Natural
11.2.1. Animal Derived
11.2.2. Microbial Derived
11.2.3. Plant Derived
11.3. Synthetic
11.3.1. Biotechnology
11.3.2. Chemical Synthesis
12. Kairomones Market, by Formulation
12.1. Introduction
12.2. Gas
12.2.1. Aerosol
12.2.2. Vapor
12.3. Liquid
12.3.1. Emulsion
12.3.2. Solution
12.4. Solid
12.4.1. Granule
12.4.2. Powder
13. Americas Kairomones Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Kairomones Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Kairomones Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Suterra LLC
16.3.2. ISCA Technologies, Inc.
16.3.3. Bedoukian Research, Inc.
16.3.4. Russell IPM Limited
16.3.5. Trécé, Inc.
16.3.6. Contech International, Inc.
16.3.7. Pacific Biocontrol Corporation
16.3.8. Pherobank B.V.
16.3.9. Koppert B.V.
16.3.10. Olfasense GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. KAIROMONES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL KAIROMONES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL KAIROMONES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL KAIROMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL KAIROMONES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL KAIROMONES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL KAIROMONES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL KAIROMONES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL KAIROMONES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL KAIROMONES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL KAIROMONES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL KAIROMONES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL KAIROMONES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL KAIROMONES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS KAIROMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS KAIROMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES KAIROMONES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES KAIROMONES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. KAIROMONES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. KAIROMONES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. KAIROMONES MARKET: RESEARCHAI
FIGURE 26. KAIROMONES MARKET: RESEARCHSTATISTICS
FIGURE 27. KAIROMONES MARKET: RESEARCHCONTACTS
FIGURE 28. KAIROMONES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. KAIROMONES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL KAIROMONES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL KAIROMONES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL KAIROMONES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL KAIROMONES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL KAIROMONES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL KAIROMONES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL KAIROMONES MARKET SIZE, BY ANIMAL BEHAVIOR RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL KAIROMONES MARKET SIZE, BY ANIMAL BEHAVIOR RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL KAIROMONES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL KAIROMONES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL KAIROMONES MARKET SIZE, BY PEST CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL KAIROMONES MARKET SIZE, BY PEST CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL KAIROMONES MARKET SIZE, BY CROP PROTECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL KAIROMONES MARKET SIZE, BY CROP PROTECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL KAIROMONES MARKET SIZE, BY URBAN PEST CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL KAIROMONES MARKET SIZE, BY URBAN PEST CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL KAIROMONES MARKET SIZE, BY PEST CONTROL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL KAIROMONES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL KAIROMONES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL KAIROMONES MARKET SIZE, BY PLANT DEFENSE RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL KAIROMONES MARKET SIZE, BY PLANT DEFENSE RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL KAIROMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL KAIROMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL KAIROMONES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL KAIROMONES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL KAIROMONES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL KAIROMONES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL KAIROMONES MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL KAIROMONES MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL KAIROMONES MARKET SIZE, BY CROP PROTECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL KAIROMONES MARKET SIZE, BY CROP PROTECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL KAIROMONES MARKET SIZE, BY LIVESTOCK MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL KAIROMONES MARKET SIZE, BY LIVESTOCK MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL KAIROMONES MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL KAIROMONES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL KAIROMONES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL KAIROMONES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL KAIROMONES MARKET SIZE, BY COSMETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL KAIROMONES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL KAIROMONES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL KAIROMONES MARKET SIZE, BY NON VOLATILE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL KAIROMONES MARKET SIZE, BY NON VOLATILE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL KAIROMONES MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL KAIROMONES MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL KAIROMONES MARKET SIZE, BY PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL KAIROMONES MARKET SIZE, BY PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL KAIROMONES MARKET SIZE, BY NON VOLATILE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL KAIROMONES MARKET SIZE, BY VOLATILE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL KAIROMONES MARKET SIZE, BY VOLATILE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL KAIROMONES MARKET SIZE, BY NITROGEN VOLATILES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL KAIROMONES MARKET SIZE, BY NITROGEN VOLATILES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL KAIROMONES MARKET SIZE, BY SULFUR VOLATILES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL KAIROMONES MARKET SIZE, BY SULFUR VOLATILES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL KAIROMONES MARKET SIZE, BY VOLATILE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL KAIROMONES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL KAIROMONES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL KAIROMONES MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL KAIROMONES MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL KAIROMONES MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL KAIROMONES MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL KAIROMONES MARKET SIZE, BY MICROBIAL DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL KAIROMONES MARKET SIZE, BY MICROBIAL DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL KAIROMONES MARKET SIZE, BY PLANT DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL KAIROMONES MARKET SIZE, BY PLANT DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL KAIROMONES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL KAIROMONES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL KAIROMONES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL KAIROMONES MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL KAIROMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL KAIROMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL KAIROMONES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL KAIROMONES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL KAIROMONES MARKET SIZE, BY GAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL KAIROMONES MARKET SIZE, BY GAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL KAIROMONES MARKET SIZE, BY AEROSOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL KAIROMONES MARKET SIZE, BY AEROSOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL KAIROMONES MARKET SIZE, BY VAPOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL KAIROMONES MARKET SIZE, BY VAPOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL KAIROMONES MARKET SIZE, BY GAS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL KAIROMONES MARKET SIZE, BY GAS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL KAIROMONES MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL KAIROMONES MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL KAIROMONES MARKET SIZE, BY EMULSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL KAIROMONES MARKET SIZE, BY EMULSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL KAIROMONES MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL KAIROMONES MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL KAIROMONES MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL KAIROMONES MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL KAIROMONES MARKET SIZE, BY SOLID, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL KAIROMONES MARKET SIZE, BY SOLID, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL KAIROMONES MARKET SIZE, BY GRANULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL KAIROMONES MARKET SIZE, BY GRANULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL KAIROMONES MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL KAIROMONES MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL KAIROMONES MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL KAIROMONES MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS KAIROMONES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS KAIROMONES MARKET SIZE, BY PEST CONTROL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS KAIROMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS KAIROMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS KAIROMONES MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS KAIROMONES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS KAIROMONES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS KAIROMONES MARKET SIZE, BY NON VOLATILE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS KAIROMONES MARKET SIZE, BY VOLATILE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS KAIROMONES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS KAIROMONES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS KAIROMONES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS KAIROMONES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS KAIROMONES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS KAIROMONES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS KAIROMONES MARKET SIZE, BY GAS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS KAIROMONES MARKET SIZE, BY GAS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS KAIROMONES MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS KAIROMONES MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS KAIROMONES MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS KAIROMONES MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS KAIROMONES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES KAIROMONES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES KAIROMONES MARKET SIZE, BY PEST CONTROL, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES KAIROMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES KAIROMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES KAIROMONES MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES KAIROMONES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES KAIROMONES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES KAIROMONES MARKET SIZE, BY NON VOLATILE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES KAIROMONES MARKET SIZE, BY VOLATILE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES KAIROMONES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES KAIROMONES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES KAIROMONES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES KAIROMONES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES KAIROMONES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES KAIROMONES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES KAIROMONES MARKET SIZE, BY GAS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES KAIROMONES MARKET SIZE, BY GAS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES KAIROMONES MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES KAIROMONES MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES KAIROMONES MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES KAIROMONES MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES KAIROMONES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES KAIROMONES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 187. CANADA KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA KAIROMONES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2024 (USD MILLION)
TABLE 190. CANADA KAIROMONES MARKET SIZE, BY PEST CONTROL, 2025-2030 (USD MILLION)
TABLE 191. CANADA KAIROMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. CANADA KAIROMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. CANADA KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 194. CANADA KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 195. CANADA KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 196. CANADA KAIROMONES MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 197. CANADA KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2024 (USD MILLION)
TABLE 198. CANADA KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2025-2030 (USD MILLION)
TABLE 199. CANADA KAIROMONES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 200. CANADA KAIROMONES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 201. CANADA KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2024 (USD MILLION)
TABLE 202. CANADA KAIROMONES MARKET SIZE, BY NON VOLATILE, 2025-2030 (USD MILLION)
TABLE 203. CANADA KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2024 (USD MILLION)
TABLE 204. CANADA KAIROMONES MARKET SIZE, BY VOLATILE, 2025-2030 (USD MILLION)
TABLE 205. CANADA KAIROMONES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 206. CANADA KAIROMONES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 207. CANADA KAIROMONES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 208. CANADA KAIROMONES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 209. CANADA KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 210. CANADA KAIROMONES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 211. CANADA KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 212. CANADA KAIROMONES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 213. CANADA KAIROMONES MARKET SIZE, BY GAS, 2018-2024 (USD MILLION)
TABLE 214. CANADA KAIROMONES MARKET SIZE, BY GAS, 2025-2030 (USD MILLION)
TABLE 215. CANADA KAIROMONES MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 216. CANADA KAIROMONES MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 217. CANADA KAIROMONES MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 218. CANADA KAIROMONES MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 219. MEXICO KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. MEXICO KAIROMONES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. MEXICO KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2024 (USD MILLION)
TABLE 222. MEXICO KAIROMONES MARKET SIZE, BY PEST CONTROL, 2025-2030 (USD MILLION)
TABLE 223. MEXICO KAIROMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. MEXICO KAIROMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. MEXICO KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 226. MEXICO KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO KAIROMONES MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 229. MEXICO KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2024 (USD MILLION)
TABLE 230. MEXICO KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2025-2030 (USD MILLION)
TABLE 231. MEXICO KAIROMONES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 232. MEXICO KAIROMONES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2024 (USD MILLION)
TABLE 234. MEXICO KAIROMONES MARKET SIZE, BY NON VOLATILE, 2025-2030 (USD MILLION)
TABLE 235. MEXICO KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO KAIROMONES MARKET SIZE, BY VOLATILE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO KAIROMONES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO KAIROMONES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO KAIROMONES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 240. MEXICO KAIROMONES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 241. MEXICO KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 242. MEXICO KAIROMONES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 243. MEXICO KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. MEXICO KAIROMONES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. MEXICO KAIROMONES MARKET SIZE, BY GAS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO KAIROMONES MARKET SIZE, BY GAS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO KAIROMONES MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 248. MEXICO KAIROMONES MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 249. MEXICO KAIROMONES MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 250. MEXICO KAIROMONES MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL KAIROMONES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL KAIROMONES MARKET SIZE, BY PEST CONTROL, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL KAIROMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL KAIROMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL KAIROMONES MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL KAIROMONES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL KAIROMONES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL KAIROMONES MARKET SIZE, BY NON VOLATILE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL KAIROMONES MARKET SIZE, BY VOLATILE, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL KAIROMONES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL KAIROMONES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL KAIROMONES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL KAIROMONES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL KAIROMONES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL KAIROMONES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL KAIROMONES MARKET SIZE, BY GAS, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL KAIROMONES MARKET SIZE, BY GAS, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL KAIROMONES MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL KAIROMONES MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL KAIROMONES MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL KAIROMONES MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA KAIROMONES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA KAIROMONES MARKET SIZE, BY PEST CONTROL, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA KAIROMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA KAIROMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA KAIROMONES MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA KAIROMONES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA KAIROMONES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA KAIROMONES MARKET SIZE, BY NON VOLATILE, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA KAIROMONES MARKET SIZE, BY VOLATILE, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA KAIROMONES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA KAIROMONES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA KAIROMONES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA KAIROMONES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA KAIROMONES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA KAIROMONES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA KAIROMONES MARKET SIZE, BY GAS, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA KAIROMONES MARKET SIZE, BY GAS, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA KAIROMONES MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA KAIROMONES MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA KAIROMONES MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA KAIROMONES MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY PEST CONTROL, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY NON VOLATILE, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY VOLATILE, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY GAS, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY GAS, 2025-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 349. UNITED KINGDOM KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 350. UNITED KINGDOM KAIROMONES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 351. UNITED KINGDOM KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2024 (USD MILLION)
TABLE 352. UNITED KINGDOM KAIROMONES MARKET SIZE, BY PEST CONTROL, 2025-2030 (USD MILLION)
TABLE 353. UNITED KINGDOM KAIROMONES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 354. UNITED KINGDOM KAIROMONES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 355. UNITED KINGDOM KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 356. UNITED KINGDOM KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 357. UNITED KINGDOM KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 358. UNITED KINGDOM KAIROMONES MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 359. UNITED KINGDOM KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2024 (USD MILLION)
TABLE 360. UNITED KINGDOM KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2025-2030 (USD MILLION)
TABLE 361. UNITED KINGDOM KAIROMONES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 362. UNITED KINGDOM KAIROMONES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 363. UNITED KINGDOM KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2024 (USD MILLION)
TABLE 364. UNITED KINGDOM KAIROMONES MARKET SIZE, BY NON VOLATILE, 2025-2030 (USD MILLION)
TABLE 365. UNITED KINGDOM KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2024 (USD MILLION)
TABLE 366. UNITED KINGDOM KAIROMONES MARKET SIZE, BY VOLATILE, 2025-2030 (USD MILLION)
TABLE 367. UNITED KINGDOM KAIROMONES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 368. UNITED KINGDOM KAIROMONES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 369. UNITED KINGDOM KAIROMONES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 370. UNITED KINGDOM KAIROMONES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 371. UNITED KINGDOM KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 372. UNITED KINGDOM KAIROMONES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 373. UNITED KINGDOM KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 374. UNITED KINGDOM KAIROMONES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 375. UNITED KINGDOM KAIROMONES MARKET SIZE, BY GAS, 2018-2024 (USD MILLION)
TABLE 376. UNITED KINGDOM KAIROMO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Kairomones market report include:
  • Suterra LLC
  • ISCA Technologies, Inc.
  • Bedoukian Research, Inc.
  • Russell IPM Limited
  • Trécé, Inc.
  • Contech International, Inc.
  • Pacific Biocontrol Corporation
  • Pherobank B.V.
  • Koppert B.V.
  • Olfasense GmbH